ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹19 Cr | ₹126 Cr | ₹18 Cr | ₹92 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of ORCHID PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹126 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹92 Cr |
| Mar2021 | ₹24 Cr |
How is Cash Flow from Operating Activities of ORCHID PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | -84.75 | |
| Mar2024 | ₹126 Cr | 587.05 | |
| Mar2023 | ₹18 Cr | -80.17 | |
| Mar2022 | ₹92 Cr | 292.08 | |
| Mar2021 | ₹24 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,727.4 Cr | 5.8% | -21.8% | -43.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,879.0 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | 5.8% |
-21.8% |
-43.1% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses